May we track your activity on this site?

We use cookies and other trackers to monitor the effectiveness of our ad campaigns. You may withdraw your consent at any time by re-opening these options.

SPECIAL CO-LOCATED SYMPOSIA: PEDIATRIC LIPID SYMPOSIUM

Pediatric Lipidology - A Primer for Clinical Practice  

 

ABOUT THE SYMPOSIUM

On June 8th and 9th, in conjunction with the IAS, we will present the first ever course devoted specifically to Pediatric Lipidology. The full range of disorders that present to pediatric lipidologists will be covered including familial hypercholesterolemia, hypertriglyceridemia, and rarer disorders. Special sessions will focus on the life course, primordial prevention, and lifetime risk assessment. An International team of experts will present material including didactic material, case presentations, panel discussions, and audience interaction sessions.

Please join us.

Sam Gidding, for the Organizing Committee

 

SYMPOSIUM DETAILS

Date/Time: Friday June 8, 13:00 - 18:00 + Saturday June 9, 08:30 - 15:45
Location: Metro Toronto Convention Centre (MTCC)

 

 

SYMPOSIUM PROGRAM 

Friday 

TimePresentationSpeaker
13:00 - 15:00 Session 1 Primordial Prevention  (McCrindle/Gidding (session chairs))
13:00 - 13:15 Greetings
13:15 - 13:45 Opening Lecture: Pediatric Dyslipidemia and Lifetime Risk Olli Raitakari MD
13:45 - 14:05 Promoting Cardiovascular Health for Children: Diet Linda Van Horn PhD
14:05 - 14:25 Promoting Cardiovascular Health for Children: School Health Laura Hayman, RN
14:25 - 14:50 How to Start a Pediatric Prevention clinic  Amy Peterson MD
14:50 - 15:00 Discussion 
15:00 - 15:15 Break 
15:15 - 18:00 Session 2 Hypertriglyceridemia and Rare Genetic Disorders   Wilson/St. Pierre session chairs
15:15 - 15:35 Session Introduction, Morbidity of High TGs Anne Tybjaerg-Hansen
15:35 - 17:00 Causes and Treatment of Hypertriglyceridemia with Case Discussions  Henry Ginsberg/Don Wilson/Julie St Pierre
17:00 - 17:20 New Treatments for Hypertriglyceridemia Daniel Gaudet
17:20 - 17:45 Rare Genetic Disorders of Lipid and Lipoprotein Metabolism Eliot Brinton
17:45 - 18:00 Closing Remarks   

Saturday 

07:00 - 08:30 Alexion Breakfast Symposium  
08:30 - 12:00 Session 5 Familial Hypercholesterolemia Neal/Wiegman session chairs
08:30 - 08:45 Audience participation: Finding FH  Steve Daniels
08:45 - 09:10 Genetics of Elevated Cholesterol Rob Hegele
09:10 - 09:30 Screening: Universal, Cascade or Both Brian McCrindle
09:30 - 10:00 Patient Evaluation: A patient encounter for FH Amy Sturm/ Catherine Mcneil /Patient
10:00 - 10:15 Break
10:15 - 10:45 Treatment of HoFH and HeFH  Albert Wiegman
10:45 - 11:30 Registries From Around the World
FH foundation
Designate/FH Canada/Safeheart
Steve Humphries & Richard Ceska
11:30 - 11:50 Audience Participation: Define FH Dan Rader/Joep Defesche
11:50 - 12:00 Closing Remarks
12:00 - 13:00 Lunch
13:00 - 14:45 Session 6 Defining the High Risk Pediatric Patient Gidding/Sturm session chairs
13:00 - 13:20 Diabetes and CVD Risk in Childhood Elaine Urbina
13:20 - 13:40 Pediatric Conditions That Accelerate CVD Risk Sarah de Ferranti
13:40 - 14:00 Lp(a)  Borge Nordestgaard
14:00 - 14:20 Risk Factors and Atherosclerosis Sam Gidding
14:20 - 14:45 Genetic Evaluation, Precision Medicine, and Future Risk Kees Hovingh
14:45 - 15:00 Break
15:00 - 15:45 Closing Session Gerald Watts moderator
  Panel Discussion: Consider whether childhood/adolescence the right time to initiate lipid treatment, if so which patients, what further evidence is needed to add additional testing, cost and patient acceptance, does enhanced knowledge improve compliance  Panelists: Gidding, Wiegman, Daniels, Kastelein, Hegele
  Closing Remarks